SIREN : 317586808
EXPANSCIENCE is a French company founded 47 years ago, specialized in the sector Gestion de fonds. Based in COURBEVOIE (92400), this company of category ETI shows in 2024 a revenue of 23.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-25
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23 413 273 € | 22 105 847 € | 22 086 638 € | 20 331 259 € | 19 611 513 € | 19 667 141 € | 20 735 052 € | 20 708 748 € | 21 128 096 € |
| Net income | 5 875 819 € | 7 238 438 € | 8 621 219 € | -1 537 102 € | -9 252 869 € | -1 356 269 € | 7 547 154 € | 10 470 485 € | 11 641 897 € |
| EBITDA | 1 455 874 € | 1 494 057 € | 2 481 546 € | 1 464 659 € | 1 425 428 € | 521 566 € | 1 065 071 € | 577 826 € | -7 313 € |
| Net margin | 25.1% | 32.7% | 39.0% | -7.6% | -47.2% | -6.9% | 36.4% | 50.6% | 55.1% |
In 2024, EXPANSCIENCE achieves revenue of 23.4 M€. Revenue is growing positively over 9 years (CAGR: +1.3%). Vs 2023: +6%. After deducting consumption (0 €), gross margin stands at 23.4 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.5 M€, representing 6.2% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 5.9 M€, i.e. 25.1% of revenue. This profit can be retained or distributed to shareholders.
23 413 273 €
23 413 273 €
1 455 874 €
-1 239 193 €
5 875 819 €
6.2%
The debt ratio (= Financial debt / Equity x 100) stands at 38%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 6.8 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 35.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
37.73%
68.435%
35.483%
6.82
36.4%
In 2024, the debt ratio of EXPANSCIENCE (37.73) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of EXPANSCIENCE (68.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of EXPANSCIENCE (6.82) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 669.40. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 205.5x. Operating income very largely covers interest expenses: high safety margin.
669.402
205.464
In 2024, the liquidity ratio of EXPANSCIENCE (669.40) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of EXPANSCIENCE (205.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 79 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 43 days. The gap of 36 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 635 days of revenue, i.e. 41.3 M€ to permanently finance. Over 2016-2024, WCR increased by +60%, requiring additional financing.
41 280 878 €
79 j
43 j
0 j
635 j
Based on 62 transactions of similar company sales
in 2024,
the value of EXPANSCIENCE is estimated at
14 316 585 €
(range 4 658 733€ - 31 023 439€).
With an EBITDA of 1 455 874€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.30x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare EXPANSCIENCE with other companies in the same sector:
The revenue of EXPANSCIENCE in 2024 is 23.4 M€.
Yes, EXPANSCIENCE generated a net profit of 5.9 M€ in 2024.
The headquarters of EXPANSCIENCE is located in COURBEVOIE (92400), in the department Hauts-de-Seine.
The tax return of EXPANSCIENCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
EXPANSCIENCE operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.